Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 87201-87250 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06018610
Effectiveness of Relaxation and Massage Methods in Proximal Femur Fractures
NARecruiting
48 participants
Started: May 18, 2022 · Completed: Jan 1, 2026
1 condition1 sponsor2 locations
NCT05111288
Influence of Pulse Electromagnetic Field Therapy on Myocardial Ischemia
NARecruiting
120 participants
Started: May 18, 2022 · Completed: Nov 30, 2025
2 conditions1 sponsor2 locations
NCT04076150
Safety and Performance Study of the Optimum Transcatheter Aortic Valve
NARecruiting
5 participants
Started: May 18, 2022 · Completed: May 18, 2027
1 condition2 sponsors1 location
NCT04467723
Combination of Atezolizumab and Pirfenidone in Second-line and Beyond NSCLC
PHASE1/PHASE2Recruiting
25 participants
Started: May 18, 2022 · Completed: Aug 31, 2027
2 conditions2 sponsors2 locations
NCT04192435
Tranexamic Acid to Reduce Infection After Gastrointestinal Surgery
PHASE4Recruiting
3,300 participants
Started: May 18, 2022 · Completed: Jan 31, 2026
5 conditions2 sponsors1 location
NCT05233150
Child-Adult Relationship Enhancement in Primary Care (PriCARE) / Criando Niños Con CARIÑO (CARIÑO)
NARecruiting
1,932 participants
Started: May 18, 2022 · Completed: Jul 1, 2027
2 conditions3 sponsors2 locations
NCT05386563
taVNS on Pupillary Response and Perceptual Learning
NARecruiting
50 participants
Started: May 18, 2022 · Completed: May 31, 2028
1 condition1 sponsor1 location
NCT05364294
Molecular Diagnosis of Systemic Autoinflammatory Diseases
N/ARecruiting
300 participants
Started: May 18, 2022 · Completed: May 2, 2033
5 conditions1 sponsor1 location
NCT05258357
Landmark vs. Ultrasound-Assisted Bone Marrow Biopsy Procedure Study
NAActive, not recruiting
100 participants
Started: May 18, 2022 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT05323149
Tranexamic Acid in Traumatic Brain Injury
PHASE3Recruiting
120 participants
Started: May 18, 2022 · Completed: Oct 15, 2027
1 condition1 sponsor1 location
NCT05371483
Cardiovascular and Cognitive Implications of Central Disorders of Hypersomnolence and Their Treatments
N/AEnrolling by invitation
100 participants
Started: May 18, 2022 · Completed: Jul 31, 2026
2 conditions1 sponsor1 location
NCT05466331
Rural New England Health Study (Phase 2)
NARecruiting
220 participants
Started: May 18, 2022 · Completed: Jul 31, 2024
3 conditions7 sponsors3 locations
NCT05528055
A Study to Investigate the Safety and Tolerability of SCR-6920 Capsule in Patients With Advanced Malignant Tumors
PHASE1Recruiting
122 participants
Started: May 18, 2022 · Completed: Oct 31, 2027
2 conditions1 sponsor1 location
NCT05404048
PD-L1 PET-imaging During CAR T-cell Therapy
PHASE2Recruiting
20 participants
Started: May 18, 2022 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT04634578
Bevacizumab Treatment For Type 1 ROP
PHASE2Active, not recruiting
77 participants
Started: May 18, 2022 · Completed: Jul 31, 2027
1 condition3 sponsors26 locations
NCT05540834
Viscoelastic Testing Guided Tissue Plasminogen Activator Treatment in Acute Respiratory Failure
PHASE2Recruiting
70 participants
Started: May 18, 2022 · Completed: Dec 1, 2026
3 conditions1 sponsor1 location
NCT05918991
Interventions for English Language Learners At-Risk for ADHD
NARecruiting
300 participants
Started: May 18, 2022 · Completed: Jul 30, 2026
1 condition4 sponsors1 location
NCT05182372
Enhancing Digital CBT-I to Improve Adherence and Reduce Disparities
NARecruiting
600 participants
Started: May 18, 2022 · Completed: Aug 30, 2026
1 condition3 sponsors1 location
NCT05531799
Anal HSIL Screening Algorithm
NARecruiting
950 participants
Started: May 18, 2022 · Completed: Dec 30, 2029
1 condition3 sponsors1 location
NCT04833023
HALO Trial: Haloperidol vs Olanzapine in Hyperactive Delirium in Palliative Care Patients; A Multi-Centre, Randomised-Controlled Trial
PHASE3Recruiting
72 participants
Started: May 18, 2022 · Completed: Dec 31, 2024
5 conditions1 sponsor3 locations
NCT05081128
Efficacy in iNPH Shunting (PENS) Trial
NAActive, not recruiting
100 participants
Started: May 18, 2022 · Completed: Aug 31, 2027
1 condition2 sponsors17 locations
NCT06182787
Development of a Model for Digital Monitoring of the Mental State of the Hospitalized Patient
N/ARecruiting
130 participants
Started: May 18, 2022 · Completed: Oct 18, 2024
9 conditions1 sponsor1 location
NCT05510401
Evaluation of Safe Use of SECURIDRAP® SELFIA®
NARecruiting
108 participants
Started: May 18, 2022 · Completed: Jul 30, 2025
3 conditions2 sponsors10 locations
NCT05877352
Intraoperative Electron Radiotherapy in Rectal Cancer - A Feasibility Trial
NAActive, not recruiting
31 participants
Started: May 18, 2022 · Completed: Jul 25, 2025
2 conditions4 sponsors1 location
NCT04898829
Evaluation of PKU Explore France
NAActive, not recruiting
7 participants
Started: May 18, 2022 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT05600088
Intracoronary Cryotherapy Effect on Stabilization of Vulnerable Plaque in Patients With (N)STEMI or Unstable Angina
NARecruiting
30 participants
Started: May 18, 2022 · Completed: Jul 31, 2026
6 conditions2 sponsors5 locations
NCT06452381
Allergenicity Assessment of Green Marine Macroalga Ulva sp.
N/AActive, not recruiting
120 participants
Started: May 18, 2022 · Completed: Mar 9, 2025
1 condition2 sponsors1 location
NCT06371209
Kinematics of Ewing Amputees
N/AEnrolling by invitation
32 participants
Started: May 17, 2022 · Completed: Jul 1, 2026
4 conditions1 sponsor1 location
NCT05472792
Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy
PHASE2Recruiting
90 participants
Started: May 17, 2022 · Completed: Apr 15, 2032
2 conditions1 sponsor1 location
NCT05141604
Feasibility Test of Virtual Reality Obstacle Detection for Low Vision Walking
NAActive, not recruiting
15 participants
Started: May 17, 2022 · Completed: May 31, 2025
6 conditions2 sponsors1 location
NCT06116630
StrokeCog-BBB to Study Cognitive Outcomes Following Stroke
N/ARecruiting
350 participants
Started: May 17, 2022 · Completed: Dec 31, 2027
1 condition3 sponsors1 location
NCT04469504
Preoperative Prehabilitation for Sarcopenic Patients Prior to Pancreatic Surgery for Cancer
NARecruiting
158 participants
Started: May 17, 2022 · Completed: May 31, 2028
2 conditions3 sponsors1 location
NCT05337982
Eccentric Muscle Training, Stimulation, and Biomarkers in SCI
NARecruiting
49 participants
Started: May 17, 2022 · Completed: Dec 31, 2025
2 conditions4 sponsors2 locations
NCT05384496
Axitinib and Nivolumab for the Treatment of Mucosal Melanoma
PHASE2Recruiting
20 participants
Started: May 17, 2022 · Completed: May 31, 2026
1 condition2 sponsors2 locations
NCT05289076
Evaluation of Tumour Growth and Oncological Treatment in Patients With CRLM Using Zebra Fish Embryo Model
PHASE1/PHASE2Recruiting
40 participants
Started: May 17, 2022 · Completed: Mar 14, 2025
4 conditions3 sponsors1 location
NCT05206500
NextGen - Clinical Implication of Next Generation Sequencing
PHASE4Recruiting
100 participants
Started: May 17, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05271318
Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab (Phase 1a and 2) and Pegylated Liposomal Doxorubicin (Phase 1b) as Treatment for Ovarian Cancer.
PHASE1/PHASE2Recruiting
76 participants
Started: May 17, 2022 · Completed: Aug 31, 2027
9 conditions2 sponsors4 locations
NCT05210413
Spartalizumab and Low-dose PAzopanib in Refractory or Relapsed Solid TumOrs of Pediatric and Adults
PHASE1/PHASE2Recruiting
59 participants
Started: May 17, 2022 · Completed: Nov 17, 2027
1 condition4 sponsors9 locations
NCT05346484
A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors
PHASE1Recruiting
100 participants
Started: May 17, 2022 · Completed: Nov 30, 2026
7 conditions1 sponsor12 locations
NCT05322577
A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer.
PHASE1/PHASE2Active, not recruiting
72 participants
Started: May 17, 2022 · Completed: Mar 12, 2028
2 conditions1 sponsor42 locations
NCT05918536
Orthopedic Oncology Surgery: Navigation, Intraoperative Imaging and Virtual Reality
N/ARecruiting
45 participants
Started: May 17, 2022 · Completed: Nov 17, 2025
2 conditions3 sponsors1 location
NCT05247164
EUS-guided PORtal Vein Sampling for Circulating Tumor Cells in Pancreatic Cancer Patients
NAActive, not recruiting
70 participants
Started: May 17, 2022 · Completed: Mar 31, 2027
2 conditions1 sponsor1 location
NCT05353257
A Study to Evaluate the Efficacy and Safety of Serplulimab in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung Cancer
PHASE3Active, not recruiting
511 participants
Started: May 17, 2022 · Completed: Dec 30, 2026
1 condition1 sponsor129 locations
NCT05308654
A Study to Assess the Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma Receiving Oral ABBV-453 Tablets
PHASE1Active, not recruiting
34 participants
Started: May 17, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor21 locations
NCT05294185
Intra-operative Hyperspectral Imaging in Neurosurgery
N/ARecruiting
81 participants
Started: May 17, 2022 · Completed: Aug 31, 2024
3 conditions1 sponsor1 location
NCT05670093
Neural Pressure Support, Synchrony and Respiratory Muscle Unloading
NARecruiting
22 participants
Started: May 17, 2022 · Completed: Jun 1, 2026
1 condition1 sponsor1 location
NCT05155254
IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18)
PHASE3Active, not recruiting
407 participants
Started: May 17, 2022 · Completed: Sep 30, 2027
2 conditions3 sponsors112 locations
NCT05327946
A Study in People With Advanced Cancer to Test How Well Different Doses of BI 770371 Alone or in Combination With Ezabenlimab Are Tolerated
PHASE1Active, not recruiting
36 participants
Started: May 17, 2022 · Completed: Sep 30, 2026
1 condition1 sponsor5 locations
NCT05365828
Legacies and Futures: Measuring Roles of Resilience and Vulnerability in Pregnancy and Birth Outcomes
N/AActive, not recruiting
945 participants
Started: May 17, 2022 · Completed: Sep 30, 2025
1 condition17 sponsors14 locations
NCT05114798
Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers
NARecruiting
255 participants
Started: May 17, 2022 · Completed: Aug 31, 2027
4 conditions2 sponsors1 location